Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease.
Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease. Curr Treat Options Gastroenterol. 2007 Jun; 10(3):185-94.